Y. Liu

Also affiliated with Weill Cornell Medicine, New York University

Computer ScienceBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy”.

Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy

Cancer Research(2023)10.1158/0008-5472.can-23-2729

N/A

0.704DataRank · unranked

108 citations

Hsin‐Yi Huang, Ziyan Lin, Michela Ranieri, Shuai Li, Soumyadip Sahu +21 more

Targeting ribosome biogenesis as a novel therapeutic approach to overcome EMT-related chemoresistance in breast cancer

eLife(2023)10.7554/elife.89486

N/A

0.542DataRank · unranked

9 citations

Yue Zou, Y. Liu, S. S. Lee, Robert B. Bednarczyk, Jianting Sheng +4 more

Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.06.28.546927

N/A

0.165DataRank · unranked

2 citations

Yue Zou, Y. Liu, Sharrell B. Lee, Robert B. Bednarczyk, Jianting Sheng +4 more

Author response: Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast Cancer

(2024)10.7554/elife.89486.2.sa0

N/A

0DataRank · unranked

0 citations

Yue Zou, Y. Liu, Sharrell Lee, Robert B. Bednarczyk, Jianting Sheng +4 more